Andarine S4

25mg per capsule · 90 capsules

£53.99

In stock · Order before 2pm for next-day dispatch

Purity≥99% (HPLC verified)

Active ingredient25mg per capsule

Count90 capsules

ManufacturerUK — ISO certified

Overall research score

7.8 / 10

Good · Strong anabolic with hardening effects, intermediate SARM

Metric breakdown

Anabolic potency 8.5

Muscle preservation 8.0

Safety profile 6.5

Bioavailability 7.5

Research depth 7.8

Suppression risk Low

Hepatotoxicity Minimal

Compound profile

Chemical name: N-[4-[(2R)-4-[(4-Cyanophenyl)carbonyl]-2-methylpiperazinyl]-3-(trifluoromethyl)phenyl]-2-methylalanine
Molecular weight: 441.37 g/mol
Half-life: ~3 hours
Detection time: Up to 4 weeks
Research active: 25–75mg / day
Research cycle: Max 8 weeks
CAS number: 401900-40-1

Research applications

Lean mass Hardening Fat loss support Body recomposition PCT may be needed

Research use only. Scores derived from published preclinical and peer-reviewed literature. Not intended for human consumption.

Description

What Is Andarine (S4)?

Andarine (S4) is an investigational compound studied in androgen receptor pathway research. This page provides a practical research reference overview with mechanism context, evidence limits, handling notes, and batch verification standards.

Compound Profile

Name	Andarine (S4 / GTx-007)
CAS	401900-40-1
Formula	C19H18F3N3O6
Molecular Weight	441.36 g/mol
Category	Investigational non-steroidal AR-active compound
PubChem	24768755

What is andarine s4 is a common query used by researchers comparing AR-pathway references and evidence maturity across compounds.

How Does Andarine Work?

Published work describes S4 as an androgen receptor ligand evaluated for selective pathway behaviour in model systems. This page is technical reference content, not therapeutic guidance. Researchers often compare andarine vs rad-140 research when assessing selectivity models, endpoint design, and evidence quality.

What Does Current Research Say?

Preclinical literature includes AR-pathway and body-composition endpoint discussions.
Evidence quality varies by model, duration, and endpoint type.
No broad consumer therapeutic approval exists.
Interpretation should prioritize study design and method quality.

Typical search intent includes s4 dosage research use and andarine cycle length research phrasing, which should be read as literature context rather than user instruction.